Revelation Biosciences, Inc.

REVB
$1.15 (+ $0.02 + 1.77%)
Last updated: 2026-08-06 02:26 UTC
REVB Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS76135L8046
CUSIP76135L804
Market Price1.15
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio0.01
EPS82.19
Market Cap$5.2M
Book Value3.07
Price to Book0.284
Beta-0.1
52w High60.48
52w Low0.83
Next Earnings DateN/A

Revelation Biosciences, Inc. trades under ticker REVB on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US76135L8046, CUSIP 76135L804. Also searched as Revelation Biosciences.

Related researchREVB stock priceREVB share priceRevelation Biosciences stockRevelation Biosciences share price76135L804
About the Company
Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Price History